LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Return on Equity

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) currently reports a ROE of 24.32%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's ROE history and peer comparisons.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's ROE of 24.32% is lower than the Healthcare sector average of 29.33%. That is roughly 17.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's current 24.32% should be judged against Healthcare norms (sector average: 29.33%) and against LFMDP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 24.32%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A, and consider following LFMDP for alerts when major investors trade the stock.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On ROE, it currently shows 24.32% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFMDP with unrelated industries.